Showing 1571-1580 of 1635 results for "".
- Oculis In-Licenses Phase 2 Topical Anti-TNF Alpha Antibody From Novartishttps://modernod.com/news/oculis-in-licenses-phase-2-topical-anti-tnf-alpha-antibody-from-novartis/2476220/Oculis has entered into an agreement to in-license a novel topical anti-TNF alpha antibody from Novartis. Terms of the deal were not disclosed. The compound, named LME 636, is based on a proprietary single-chain antibody fragment technology specifically de
- Focus Vision Supplements Launches Reformulated Version of Omega-3 Focus Relief Plushttps://modernod.com/news/focus-vision-supplements-launches-reformulated-version-of-omega-3-focus-relief-plus/2476228/Covalent Medical, a network of over 385 ophthalmologists who distribute vision supplements sold in practitioners’ offices in the United States under the brand name Focus Vision Supplements, is launching a reformulated version of their leading omega-3 formulation Focus Relief Plus. Focus Re
- American Academy of Ophthalmology Calls on States to Maintain High Safety Standards for Surgical Eye Carehttps://modernod.com/news/american-academy-of-ophthalmology-calls-on-states-to-maintain-high-safety-standards-for-surgical-eye-care/2476237/The American Academy of Ophthalmology agrees with important patient safety guidelines recommended in a joint report issued by the three federal agencies that help guide the nation’s health care system. The report, authored by the three cabinet secretaries of the U.S. Departments of Health and Hum
- Mount Sinai Recruits Internationally Recognized Ophthalmologists to Expand Leadershiphttps://modernod.com/news/mount-sinai-recruits-internationally-recognized-ophthalmologists-to-expand-leadership/2479609/Mount Sinai Health System announced the appointment of two new faculty members to expand leadership in the Department of Ophthalmology. Louis R. Pasquale, MD, FARVO, has been named Site Chair of Ophthalmology at The Mount Sinai Hospital and Mount Sinai Queens and will also serve as Vice Chair of
- 4D Molecular Therapeutics Announces Collaboration to Advance Gene Therapies for Retinal Diseases with Oregon Health & Sciencehttps://modernod.com/news/4d-molecular-therapeutics-announces-collaboration-to-advance-gene-therapies-for-retinal-diseases-with-oregon-health-science/2476157/4D Molecular Therapeutics (4DMT) announced a research and development collaboration with the Casey Eye Institute and the Oregon National Primate Research Center at Oregon Health & Science University (OHSU). The collaboration will combine the complementary expertise of 4D Molecular Therapeutic
- MDI Biological Laboratory Scientist Receives Scientific Innovation Award for Research on AMDhttps://modernod.com/news/mdi-biological-laboratory-scientist-receives-scientific-innovation-award-for-research-on-amd/2476162/Vicki P. Losick, PhD, has been named the inaugural recipient of an award from the William Procter Scientific Innovation Fund. The award will support her research at the MDI Biological Laboratory on age-related macular degeneration (AMD). The Procter Fund was established at the MDI Biologic
- Warby Parker Eyewear Now Available to People Enrolled in UnitedHealthcare Medicare Advantage Planshttps://modernod.com/news/warby-parker-eyewear-now-available-to-people-enrolled-in-unitedhealthcare-medicare-advantage-plans/2479652/For the first time, Warby Parker is accepting Medicare insurance. The company’s designer prescription eyewear is available to approximately 2 million people enrolled in UnitedHealthcare Medicare Advantage plans, either online or at more than 80 Warby Parker stores nationwide, according to a
- American Academy of Optometry Announces Barbara Caffery, OD, PhD, FAAO, as Presidenthttps://modernod.com/news/american-academy-of-optometry-names-barbara-caffery-od-phd-faao-as-president/2479665/The American Academy of Optometry has named Barbara Caffery, OD, PhD, FAAO, the incoming President of the American Academy of Optometry. Dr. Caffery was formally inducted during the Academy’s annual meeting in San Antonio, Texas on November 10, 2018. She is the first Canadian woman to serve as pr
- Johnson & Johnson Vision Announce $26.35 Million Collaboration for Prevention and Treatment of Myopiahttps://modernod.com/news/johnson-johnson-vision-announce-26-35-million-collaboration-for-prevention-and-treatment-of-myopia/2479677/The Singapore National Eye Centre (SNEC), the Singapore Eye Research Institute (SERI), and Johnson & Johnson Vision announced a $26.35 million research collaboration to tackle myopia. By 2050, half of the world’s population are projected to be myopic, with one billion expected to have high my
- New CorneaGen Interactive Education Program To Offer Free Online Training for Surgeonshttps://modernod.com/news/new-corneagen-interactive-education-program-to-offer-free-online-training-for-all-surgeons/2479755/CorneaGen is adding interactive, online courses to its free education program for surgeons around the world. Utilizing an online platform designed for universities, CorneaGen will offer instruction in cutting-edge procedures such as Nano-Thin DSEK and best practices for using transplant devices.